Stay updated on Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa
Sign up to get notified when there's something new on the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page.

Latest updates to the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe NIH transition announcement banner was removed from the top of the page. The underlying study page still shows a 403 error.SummaryDifference1%

- Check14 days agoChange DetectedThe footer's site revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434, with links to updates and FAQs. It appears above the 403 error page and does not change any study details.SummaryDifference1%

- Check28 days agoChange DetectedThe site revision label in the page footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check56 days agoChange DetectedA 403 Forbidden page is now shown, and substantial study-document content appears to have been removed from the page, reducing the amount of study information and materials visible to users.SummaryDifference23%

Stay in the know with updates to Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa
Enter your email address, and we'll notify you when there's something new on the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page.